Blog
12-16-2024Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not reduce the time to lesion resolution...
Clinical Trials
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain - Blog
Help Scientists Find a Safe and Effective Mpox Treatment 05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can.… - Blog
Clinical Trial Evaluating Monkeypox Vaccine Begins 09-09-2022Cross-posted from NIAID Newsroom NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply.... - Blog
Happy Heart Month: What People Living with HIV Should Know 02-14-2018Cross-posted fromNIAID Now BlogToday marks not just a time to exchange valentines and chocolates, but also th... - Blog
NIH and Partners Launch HIV Vaccine Efficacy Study 11-30-2017 - Blog
Focusing the Science-Driven HIV Research Enterprise 09-21-2017 - Blog
NIAID Supports Research Towards Healthy Aging for People Living with HIV 09-18-2017 - Blog
This February, Take Heart: NIH is Committed to Preventing HIV-Related Heart Attacks and Strokes 02-14-2017 - Blog
Historic HIV Vaccine Clinical Trial: Facebook Live with NIH’s Dr. Dieffenbach 12-02-2016In a Facebook Live interview from Cape Town, South Africa earlier this week, we heard from NIH’s Dr. Carl Dieffenbach about the exciting launch of HVTN 70… - Blog
NIH Statement on World AIDS Day 2016 12-01-2016This year, the world marked the 35th anniversary of the first published reports of what would come to be known as HIV/AIDS. This disease has wrought enormous su… - Blog
Watch HIV Vaccine Trial Launch in South Africa Via Facebook Live! This Wednesday! 11-29-2016When: Wednesday, November 30, at 2:00 p.m. (ET).How: Follow the HIV.gov Facebook page and you will receive a notification in the top right corner when this... - Blog
First New HIV Vaccine Efficacy Study in Seven Years Has Begun 11-28-2016South Africa Hosts Historic NIH-Supported Clinical Trial November 27, 2016The first HIV vaccine efficacy study to launch anywhere in seven years is now testing.… - Blog
ICYMI – Advances in Research on HIV Prevention for Women 10-27-2016Earlier this year at AIDS 2016 in Durban, South Africa, the ASPIRE study reported that using a drug-infused vaginal ring most or all of the time reduced the ri.… - Blog
REPRIEVE Trial To Host Second Twitter Chat, #HIVAgingChat 09-13-2016 - Blog
NIH’s Dr. Dieffenbach Shares Final Update from AIDS 2016 07-20-2016 - Blog
HIV Vaccine Research: Update from NIH’s Dr. Dieffenbach from 2nd Day of AIDS 2016 07-19-2016As the second day of the International AIDS Conference (AIDS 2016) came to a close in Durban, South Africa, we caught up with Dr. Carl Dieffenbach again via&nbs… - Blog
NIH’s Dr. Dieffenbach Shares Perspectives from First Day of AIDS 2016 07-18-2016The 21st International AIDS Conference (AIDS 2016) opened in Durban, South Africa today. As we've done from other scientific conferences, we caught up with Dr..… - Blog
Vaginal Ring May Cut HIV Infection Risk if Used Consistently 07-18-2016 - Blog
NIH’s Dr. Carl Dieffenbach Shares Highlights as IAS 2015 Begins 07-21-2015After the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) got underway in Vancouver, Canada yesterday, July 2… - Blog
International Study Demonstrates Benefits of Early HIV Treatment 06-01-2015The question of when to initiate antiretroviral therapy (ART) during the course of HIV infection has been debated for years, yet a conclusive answer has remaine…